• Our Products
    • Overview
    • Breast Cancer
    • Hereditary Cancer
    • Prostate Cancer
    • Precision Medicine
    • Melanoma
  • Patients
    • Your Questions About Disease
    • Hereditary Cancer Quiz
  • News Center
  • Locations
  • Contact us
  • About Myriad
    • Myriad History
    • Management Team
    • Myriad International Fact Sheet
    • Joining the Myriad Team
    • Myriad’s Response To COVID-19
Back to Blog

Prolaris®

July 17, 2014
  • Share

Prolaris®

Prolaris®

Prolaris aids healthcare professionals in predicting prostate cancer aggressiveness and disease progression.

FacebookTwitterLinkedIn

Myriad Genetics GmbH
Leutschenbachstrasse 95
8050 Zurich
Switzerland

Tel.: +41 44 939 91 30
info@myriadgenetics.eu

Privacy

  • Terms of Use
  • Privacy Policy
  • Data Protection and Privacy Statement

Copyright © 2020 Myriad Genetics
all rights reserved


















  • Terms of Use
  • Privacy Policy
  • Data Protection and Privacy Statement
  • Site Map
  • Contact Us
© 2021 Myriad Internationalxxx
This website intends to use cookies. Cookies provide information on the way that you use the website in order to improve your experience and to make statistics. By continuing to browse the site, you are agreeing to accept our use of “cookies”. You will find more information about “cookies” on our privacy policy page.